Antithrombotic therapy in COVID-19 patients-Reference-Cited by-同舟云学术

Antithrombotic therapy in COVID-19 patients

Published:2023-01-15 Issue:6 Volume:16 Page:718-731
ISSN:2500-3194
Container-title:Obstetrics, Gynecology and Reproduction
language:
Short-container-title:Akušerstvo, ginekologiâ i reprodukciâ

Author:

Slukhanchuk E. V.¹^ORCID,Bitsadze V. O.¹^ORCID,Khizroeva J. Kh.¹^ORCID,Tretyakova M. V.¹^ORCID,Shkoda A. S.²^ORCID,Blinov D. V.³^ORCID,Tsibizova V. I.⁴^ORCID,Jinbo Z.¹,Sheena S.¹,Sсhulman S.⁵^ORCID,Gris J.-K.⁶^ORCID,Elalamy I.⁷^ORCID,Makatsariya A. D.¹^ORCID

Affiliation:

1. Sechenov University

2. Vorokhobov City Clinical Hospital № 67, Moscow City Healthcare Department

3. Sechenov University; Institute for Preventive and Social Medicine; Moscow Haass Medical – Social Institute

4. Almazov National Medical Research Centre, Health Ministry of Russian Federation

5. Sechenov University; McMaster University

6. Sechenov University; University of Montpellier

7. Sechenov University; Medicine Sorbonne University; Hospital Tenon

Abstract

Recently, there have been published the data of large randomized trials on the use of antithrombotic agents for reducing a risk of thromboembolic complications, multiple organ failure and mortality in COVID-19 patients. However, principles of selecting optimal therapy remain open. Strategies for the use of antithrombotic drugs in outpatient and inpatient settings, thromboprophylaxis in specific patient populations, and treatment of acute thrombosis in hospitalized COVID-19 patients are being developed. In October 2021, the International Society on Thrombosis and Hemostasis (ISTH) formed an interdisciplinary international panel of experts to develop recommendations for use of anticoagulants and antiplatelet agents in COVID-19 patients. Expert opinions are published. Here, we summarize all the publications available globally at the present time on this issue, obtained by using the principles of evidence-based medicine.

Publisher

IRBIS

Subject

Obstetrics and Gynecology,Embryology,Reproductive Medicine

Reference87 articles.

1. Schulman S., Sholzberg M., Spyropoulos A.C. et al. ISTH guidelines for antithrombotic treatment in COVID-19. J Thromb Haemost. 2022;20(10):2214–25. https://doi.org/10.1111/jth.15808.

2. Spyropoulos A.C., Connors J.M., Douketis J.D. et al. Good practice statements for antithrombotic therapy in the management of COVID-19: Guidance from the SSC of the ISTH. J Thromb Haemost. 2022;20(10):2226–36. https://doi.org/10.1111/jth.15809.

3. Piazza G., Campia U., Hurwitz S. et al. Registry of arterial and venous thromboembolic complications in patients with COVID-19. J Am Coll Cardiol. 2020;76(18):2060–72. https://doi.org/10.1016/j.jacc.2020.08.070.

4. Giannis D., Barish M.A., Goldin M. et al. Incidence of venous thromboembolism and mortality in patients with initial presentation of COVID-19. J Thromb Thrombolysis. 2021;51(4):897–901. https://doi.org/10.1007/s11239-021-02413-7.

5. Ilowite J., Lisker G., Greenberg H. Digital health technology and telemedicine-based hospital and home programs in pulmonary medicine during the COVID-19 pandemic. Am J Ther. 2021;28(2):e217–e223. https://doi.org/10.1097/MJT.0000000000001342.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alexander D. Makatsariya is 2022 Best Author;Obstetrics, Gynecology and Reproduction;2023-03-06